Engalla, Baby Boy .

HRN: 27-56-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/29/2025
08/04/2025
IVT
30mg
Q24
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: